Mentice Ab · OMXSTO:MNTC
Mentice Ab — Investor Presentation (June 2026)
16 slides from Mentice Ab's investor presentation, Jun 24, 2026
Slide 1: Mentice Company Overview 2026
Mentice Company Overview 2026 24.06.2026
Slide 2: Today's speaker
INTRODUCTION Today’s speaker Frans Venker – CEO • CEO and President of Mentice since January 1, 2025. • More than 25 years of experience in the global healthcare and MedTech industry, including management roles at Philips in North America, China and Europe. • MSc in Applied Physics from the Universi
Slide 3: Company Overview
INTRODUCTION Company Overview 1 Mentice and the Global Healthcare Challenge 2 Market Opportunity and Strategic Direction 3 Concluding Remarks 3
Slide 4: Solutions to help solve global clinical challenges
SOLUTIONS TO HELP SOLVE GLOBAL CLINICAL CHALLENGES Every patient deserves the best possible care 4
Slide 5: Mentice today
ABOUT MENTICE Mentice today 1999 60+ 1050 + Engineers in research Founded Customers and development 129 3450+ 140+ Endovascular simulation Full time employees Systems sold worldwide papers & articles 60+ MNTC >50% 8 Patents & patent Listed at Nasdaq first Global market share pending applications nor
Slide 6: Global healthcare is a perfect storm of challenges
THE GLOBAL HEALTH CARE CHALLENGE Global healthcare is a perfect storm of challenges Trends affecting our society Rapidly aging population Rising healthcare costs Rising labor costs & staff shortages 15% of hospital expenditure in high-income countries due to medical errors Geography & population den
Slide 7: Cardiovascular diseases are the leading cause of death globally
THE GLOBAL HEALTH CARE CHALLENGE Cardiovascular diseases are the leading cause of death globally Where we make a difference 919,032 19.2 m 48% Endovascular interventions are critical for treating these conditions, deaths caused by Deaths related to of US adults had some but require highly cardiovasc
Slide 8: Endovascular surgery is growing at rapid pace
THE GLOBAL HEALTH CARE CHALLENGE Endovascular surgery is growing at rapid pace Endovascular surgery, using Image-Guided Therapies (IGT), has several key benefits: Less pain & anesthesia Higher patient age limit Lower risk of complications Minimal incision Shorter recovery time Shorter hospital stay
Slide 9: Our role in supporting the industry and hospitals
THE GLOBAL HEALTH CARE CHALLENGE Our role in supporting the industry and hospitals Device training Procedure training 83% of sales* 17% of sales* Medical Hospital / Improving Device Healthcare patient Mentice partners with the Mentice’s products help Industry Systems outcomes Medical Device Industry
Slide 10: Our main products and solutions
THE GLOBAL HEALTH CARE CHALLENGE Our main products and solutions VR Simulators Physiological Flow Systems Ankyras Decision Support VIST® G7 unique patent protected CE marked and FDA cleared Physiological flow models and platform with comprehensive support clinical application for intracranial vessel
Slide 11: Business areas and customers
ABOUT MENTICE Business areas and customers Medical Device Industry (MDI) Healthcare Systems (HCS) • Design and clinical evaluation • OEM Integration with partners • Hospitals and universities • Product launch support • Integration into Cath Labs • Training, planning, rehearsal & • Training, sales an
Slide 12: Market Opportunity and Strategic Direction
MARKET OPPORTUNITY AND STRATEGIC DIRECTION 12
Slide 13: Market Size and Growth Opportunity
MARKET OPPORTUNITY AND STRATEGIC DIRECTION Market Size and Growth Opportunity 200,000 practicing physicians IGIT Performance Solutions $500M 40’000 AVAILABLE MARKET (single-digit growth) Cath Labs $75M 15–20 million CURRENT MARKET (double-digit growth) procedures performed annually Source: American
Slide 14: Strengthening of MDI will lead towards clinical use
MARKET OPPORTUNITY AND STRATEGIC DIRECTION Strengthening of MDI will lead towards clinical use Basic training: Clinical education, Advanced training: Advanced cases Clinical use: Procedure rehearsal, marketing and onboarding and case customization real time support and guidance Procedure step educat
Slide 15: Case: Real patient impact
MARKET OPPORTUNITY AND STRATEGIC DIRECTION Case: Real patient impact Flow model anatomical replication 01 A complex case of a child with critical brain aneurysms, initially considered for open surgery with uncertain outcomes, was evaluated using Mentice simulation platform. 02 Using our neurovascula
Slide 16: Thank you for watching
Thank you for watching Mentice AB mentice.com